Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 09:36 am Sale |
2024-09-30 | 13G | HilleVax, Inc. HLVX |
Deep Track Capital, LP | 0 0.000% |
-2,900,000 (Position Closed) |
Filing History |
| 2024-11-14 09:00 am Sale |
2024-09-30 | 13G | HilleVax, Inc. HLVX |
Flynn James E | 1,882,654 3.780% |
-2,121,577 (-52.98%) |
Filing History |
| 2024-07-22 9:02 pm Purchase |
2024-07-12 | 13G | HilleVax, Inc. HLVX |
TANG CAPITAL PARTNERS LP | 4,712,954 9.500% |
4,712,954 (New Position) |
Filing History |
| 2024-05-31 2:00 pm Purchase |
2024-05-29 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 10,639,562 21.400% |
833,090 (+8.50%) |
Filing History |
| 2024-02-14 6:46 pm Purchase |
2023-12-31 | 13G | HilleVax, Inc. HLVX |
Lightspeed Venture Partners Select IV L.P. | 2,313,432 4.800% |
400,000 (+20.90%) |
Filing History |
| 2024-02-14 5:01 pm Sale |
2023-12-31 | 13G | HilleVax, Inc. HLVX |
RA Capital Management, L.P. | 0 0.000% |
-1,760,019 (Position Closed) |
Filing History |
| 2024-02-14 08:45 am Unchanged |
2023-12-31 | 13G | HilleVax, Inc. HLVX |
Deep Track Capital, LP | 2,900,000 5.990% |
0 (Unchanged) |
Filing History |
| 2024-02-12 5:27 pm Purchase |
2023-12-31 | 13G | HilleVax, Inc. HLVX |
Flynn James E | 4,004,231 8.270% |
1,310,130 (+48.63%) |
Filing History |
| 2024-02-12 4:31 pm Unchanged |
2023-12-31 | 13G | HilleVax, Inc. HLVX |
Carlyle Group Inc. CG |
1,838,486 3.800% |
0 (Unchanged) |
Filing History |
| 2023-09-29 4:15 pm Purchase |
2023-09-20 | 13G | HilleVax, Inc. HLVX |
Deep Track Capital, LP | 2,900,000 6.140% |
2,900,000 (New Position) |
Filing History |
| 2023-09-27 10:26 am Purchase |
2023-09-25 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 9,806,472 20.200% |
25,000 (+0.26%) |
Filing History |
| 2023-05-05 4:12 pm Purchase |
2023-04-28 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 9,781,472 25.000% |
144,240 (+1.50%) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | HilleVax, Inc. HLVX |
RA Capital Management, L.P. | 1,760,019 5.300% |
1,760,019 (New Position) |
Filing History |
| 2023-02-10 4:16 pm Purchase |
2022-12-31 | 13G | HilleVax, Inc. HLVX |
Carlyle Group Inc. CG |
1,838,486 5.500% |
1,838,486 (New Position) |
Filing History |
| 2023-02-10 09:33 am Purchase |
2022-12-31 | 13G | HilleVax, Inc. HLVX |
Flynn James E | 2,694,101 8.080% |
76,153 (+2.91%) |
Filing History |
| 2022-09-08 1:19 pm Purchase |
2022-09-06 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 9,637,232 28.800% |
513,660 (+5.63%) |
Filing History |
| 2022-05-13 4:31 pm Purchase |
2022-05-03 | 13G | HilleVax, Inc. HLVX |
Lightspeed Venture Partners Select IV L.P. | 1,913,432 5.700% |
1,913,432 (New Position) |
Filing History |
| 2022-05-13 4:31 pm Purchase |
2022-05-03 | 13G | HilleVax, Inc. HLVX |
Abingworth LLP | 1,838,486 5.500% |
1,838,486 (New Position) |
Filing History |
| 2022-05-09 06:08 am Purchase |
2022-04-28 | 13D | HilleVax, Inc. HLVX |
TAKEDA PHARMACEUTICAL CO LTD | 6,724,000 17.100% |
6,724,000 (New Position) |
Filing History |
| 2022-05-06 4:15 pm Purchase |
2022-04-28 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 9,123,572 27.300% |
9,123,572 (New Position) |
Filing History |